Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Express Scripts
Dow
McKinsey
Cipla
Cerilliant
Cantor Fitzgerald
UBS
AstraZeneca

Generated: May 27, 2018

DrugPatentWatch Database Preview

Mallinkrodt Nuclear Company Profile

« Back to Dashboard

What is the competitive landscape for MALLINKRODT NUCLEAR, and what generic and branded alternatives to MALLINKRODT NUCLEAR drugs are available?

MALLINKRODT NUCLEAR has eighteen approved drugs.



Summary for Mallinkrodt Nuclear
US Patents:0
Tradenames:15
Ingredients:15
NDAs:18

Drugs and US Patents for Mallinkrodt Nuclear

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinkrodt Nuclear ULTRA-TECHNEKOW FM technetium tc-99m sodium pertechnetate generator SOLUTION;INTRAVENOUS 017243-003 Feb 18, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Mallinkrodt Nuclear TECHNETIUM TC-99M SESTAMIBI technetium tc-99m sestamibi kit INJECTABLE;INJECTION 078098-001 Sep 22, 2008 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Mallinkrodt Nuclear SODIUM IODIDE I 131 sodium iodide i-131 CAPSULE;ORAL 016515-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Mallinkrodt Nuclear INDIUM IN 111 CHLORIDE indium in-111 chloride INJECTABLE;INJECTION 019841-001 Sep 27, 1994 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Mallinkrodt Nuclear

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mallinkrodt Nuclear TECHNESCAN MAG3 technetium tc-99m mertiatide kit INJECTABLE;INJECTION 019882-001 Jun 15, 1990 5,573,748 ➤ Try a Free Trial
Mallinkrodt Nuclear OCTREOSCAN indium in-111 pentetreotide kit INJECTABLE;INJECTION 020314-001 Jun 2, 1994 5,776,894 ➤ Try a Free Trial
Mallinkrodt Nuclear OCTREOSCAN indium in-111 pentetreotide kit INJECTABLE;INJECTION 020314-001 Jun 2, 1994 5,384,113 ➤ Try a Free Trial
Mallinkrodt Nuclear TECHNESCAN technetium tc-99m oxidronate kit INJECTABLE;INJECTION 018321-001 Approved Prior to Jan 1, 1982 4,497,744 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
UBS
Deloitte
Dow
Covington
Accenture
Federal Trade Commission
Colorcon
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.